FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,248 resources (JSON | CSV)

Source:
Text: Package: Only Show Used

By Version

By Authority

  • none: 2,055
  • hl7: 12,193

 

Start Prev Rows 7600 - 7800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)Usage #
hl7.fhir.us.vrdrR4ValueSet-vrdr-edit-bypass-012-vs.jsonEdit Bypass 012activepher2024-10hl7fhir2
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.918.jsonAdmission Source (HL7)active2019-01oid
us.nlm.vsacR4ValueSet-2.16.840.1.113883.1.11.12199.jsonLanguageAbilityProficiencyactive2024-06hl7tho2
us.nlm.vsacR4ValueSet-2.16.840.1.113883.1.11.12249.jsonLanguageAbilityModeactive2024-06hl7tho2
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7913.jsonCandida auris PCR result (ARLN)active2019-01sct
us.cdc.phinvadsR4ValueSet-2.16.840.1.113883.11.20.9.49.jsonResidence and Accommodation Typeactive2014-12sct
us.cdc.phinvadsR4ValueSet-2.16.840.1.113883.3.88.12.80.68.jsonProblem Statusactive2014-12sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.11.20.9.61.jsonCare Modelactive2024-06hl7sct2
us.nlm.vsacR4ValueSet-2.16.840.1.113883.1.11.19185.jsonReligious Affiliationactive2024-06hl7tho2
fhir.r4.wales.discoveryR4ValueSet-DataStandardsWales-HospitalClassification.jsonData Standards Hospital Classificationdraft2020-12hl71
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7909.jsonIdentifier type (ARLN)active2019-01tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7920.jsonInterpretation codes (ARLN)active2019-01oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7270.jsonLab Test Result Interpretation (NND)active2020-01sct tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7904.jsonProgram study or event (ARLN)active2019-01oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7914.jsonAcinetobacter culture result (ARLN)active2019-01sct tho
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7912.jsonCandida auris culture result (ARLN)active2019-01sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.11.20.7.1.jsonSupportedFileFormatsactive2024-06hl7tho2
fhir.ph.coreR4ValueSet-indigenous-groups-vs.jsonIndigenous Groupsdraft2026-03hl7internal1
fhir.r4.spirecoreR4ValueSet-SpireCore-ConsentClass.jsonSpireCore-ConsentClassdraft2025-12hl7fhir1
fhir.kenyaCoreIGR4ValueSet-ConditionCategoryVS.jsonCondition Category Value Setdraft2026-01hl7internal1
fhir.kenyaCoreIGR4ValueSet-ConditionClinicalStatusVS.jsonCondition Clinical Status Value Setdraft2026-01hl7internal2
fhir.r4.spirecoreR4ValueSet-SpireCore-ConsentPurpose.jsonSpireCore-ConsentPurposedraft2025-12hl7tho1
fhir.kenyaCoreIGR4ValueSet-ConditionVerificationStatusVS.jsonCondition Verification Status Value Setdraft2026-01hl7internal2
hl7.fhir.us.splR5ValueSet-valueset-AllNDCProducts.jsonAll NDC Productstrial-use1brr2025-07hl7ndc1
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7924.jsonMother Infant Indicator (NND)active2019-01sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.1.jsonPregnancy Statusactive2023-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.10.jsonPap Smear Testsactive2023-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.11.jsonHIV Testsactive2023-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.12.jsonHuman Papilloma Virus Testsactive2023-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.13.jsonChlamydia Trachomatis Testsactive2023-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.14.jsonNeisseria Gonorrhoeae Testsactive2023-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.17.jsonContraceptive Typeactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.18.jsonContraception Not Used Reasonactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.209.jsonYes and No Answersactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.21.jsonContraceptive Provision Methodactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.210.jsonPap Smear Resultsactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.211.jsonContraceptive discussionactive2023-08hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.24.jsonClinical Provider Roleactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.29.jsonInsurance Coverage Typeactive2023-07hl7
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.3.jsonOrganism Detectionactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1166.31.jsonEnglish Proficiencyactive2023-07hl7sct
hl7.fhir.us.vitalsR4ValueSet-LowOnlyNumericResultIntVS.jsonLow Only Numeric Result Interpretation value setdraft2024-10hl7tho2
fhir.nwgenomics.nhs.ukR4ValueSet-PatientIdentityTriggers.jsonPatient Identity Triggerdraft2026-03hl7tho
hl7.fhir.us.registry-protocolsR4ValueSet-LesionComplexity.jsonComplexity of the Lesionactivecic2023-11hl7fhir
hl7.fhir.us.registry-protocolsR4ValueSet-CABGIndication.jsonCABG Indicationactivecic2023-11hl7fhir
hl7.fhir.us.medmorphR4ValueSet-us-ph-computable-valueset-example.jsonUS Public Health Computable ValueSet Exampledraft2022-07hl7
hl7.fhir.us.ph-libraryR4ValueSet-us-ph-valueset-computable-example.jsonUS Public Health ValueSet - Computable Exampledraft2022-07hl7
hl7.fhir.us.ecr.r4bR4BValueSet-us-ph-computable-valueset-example.jsonUS Public Health Computable ValueSet Exampledraft2022-05hl7
hl7.fhir.us.breast-radiologyR4ValueSet-rde1562-laterality-from-landmark.jsonRDE1562 Laterality from landmarkdraft2022-10hl7fhir
hl7.fhir.us.breast-radiologyR4ValueSet-rde1565-type.jsonRDE1565 Typedraft2022-10hl7fhir1
hl7.fhir.us.breast-radiologyR4ValueSet-rde1568-distribution.jsonRDE1568 Distributiondraft2022-12hl7fhir9
hl7.fhir.us.breast-radiologyR4ValueSet-rde1571-associated-features.jsonRDE1571 Associated featuresdraft2022-11hl7fhir1
hl7.fhir.us.breast-radiologyR4ValueSet-rde1576-shape.jsonRDE1576 Shapedraft2022-11hl7fhir8
hl7.fhir.us.breast-radiologyR4ValueSet-rde1577-type.jsonRDE1577 Typedraft2022-10hl7fhir1
hl7.fhir.us.breast-radiologyR4ValueSet-rde1578-density.jsonRDE1578 Densitydraft2022-10hl7fhir8
hl7.fhir.us.breast-radiologyR4ValueSet-rde1579-margin.jsonRDE1579 Margindraft2022-10hl7fhir8
hl7.fhir.us.breast-radiologyR4ValueSet-rde1580-orientation.jsonRDE1580 Orientationdraft2022-10hl7fhir8
hl7.fhir.us.breast-radiologyR4ValueSet-rde1586-assessment-category.jsonRDE1586 Assessment categorydraft2022-11hl7fhir1
hl7.fhir.us.breast-radiologyR4ValueSet-rde1587-breast-composition-category.jsonRDE1587 Breast composition categorydraft2022-11hl7fhir4
hl7.fhir.us.breast-radiologyR4ValueSet-rde1588-breast-laterality.jsonRDE1588 Breast lateralitydraft2022-11hl7fhir1
hl7.fhir.us.breast-radiologyR4ValueSet-rde1589-implant-presence.jsonRDE1589 Implant presencedraft2022-11hl7fhir
hl7.fhir.us.breast-radiologyR4ValueSet-rde1590-prior-mastectomy.jsonRDE1590 Prior mastectomydraft2022-11hl7fhir
hl7.fhir.us.breast-radiologyR4ValueSet-rde1602-type.jsonRDE1602 Typedraft2022-12hl7fhir1
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1096.jsonRash Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1089.jsonBotulism-like Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1099.jsonSpecific Infection Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1091.jsonGastrointestinal Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1097.jsonRespiratory Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1095.jsonNeurological Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1098.jsonSevere Illness Or Death Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1090.jsonFever Syndrome (BT)active2008-01fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.1094.jsonLymphadenitis Syndrome (BT)active2008-01fhir
bha-test-igR4ValueSet-bha-asam-level-of-care-vs.jsonBHA ASAM Levels of Care Value Setdraft2026-03internal
bha-igR4ValueSet-bha-asam-level-of-care-vs.jsonBHA ASAM Levels of Care Value Settrial-use02026-03internal
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7702.jsonATI Method (RIBD)active2018-01sct tho
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3343.jsonAbnormal Flag (HL7 27)active2010-01oid
hl7.fhir.us.breast-radiologyR4ValueSet-rde1556-presence.jsonRDE1556 Presencedraft2022-12hl7fhir3
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.34.jsonAbnormalityOfGaitAndMobilityactive2021-07hl7icd
hl7.fhir.us.ecrR4ValueSet-2.16.840.1.113762.1.4.1146.1506-example.jsonAcanthamoeba Disease [Keratitis] (Disorders) (ICD10CM)informativepher2025-12hl7icd1
hl7.fhir.us.ecrR4ValueSet-2.16.840.1.113762.1.4.1146.1505-example.jsonAcanthamoeba Disease [Keratitis] (Disorders) (SNOMED)informativepher2025-12hl7sct1
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3344.jsonAccept Application Acknowledgment Conditions (HL7)active2017-01tho
hl7.fhir.us.mcodeR4ValueSet-mcode-tumor-size-units-vs.jsonTumor Size Units Value Setactive3cic2025-02hl7ucum1
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.958.jsonAcknowledgment Code (HL7)active2008-01tho
signal.core.r4R4valueset-questionnaire-ccars-action-types.jsonQuestionnaire CCARS Action Typesdraft1pahl7
fhir.cqf.commonR4ValueSet-active-condition.jsonCQF Active Conditionactive2019-07hl7tho
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8014.jsonActivity Type Anthraxactive2020-01tho oid
hl7.fhir.us.vrdrR4ValueSet-vrdr-activity-at-time-of-death-vs.jsonActivity at Time of Death ValueSetactivepher2024-10hl7fhir tho2
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3102.jsonSkin Exposure Activity (FDD)active2008-01tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8011.jsonActivity Type (Leptospirosis)active2020-01sct tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7985.jsonActual Route of Administration (Anthrax)active2020-01sct tho
hl7.fhir.us.nhsn-dqmR4ValueSet-ach-encounter-class.jsonAcute Care Hospital Encounter Class ValueSettrial-use1pher2025-07hl7tho
hl7.fhir.us.nhsn-dqmR4ValueSet-ach-encounter-status.jsonAcute Care Hospital Encounter Status ValueSettrial-use1pher2025-07hl7fhir
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3213.jsonSigns and Symptoms (Acute Hepatitis B)active2009-01sct
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3206.jsonLab Test Result Name (Acute Hepatitis B)active2009-01loinc
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3221.jsonDisease Type (Acute Hepatitis B)active2009-01sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.1.11.10416.jsonFinancially Responsible Party Type Value Setactive2024-06hl7tho2
us.nlm.vsacR4ValueSet-2.16.840.1.113883.11.20.9.20.jsonTelecom Use (US Realm Header)active2024-06hl7tho2
us.nlm.vsacR4ValueSet-2.16.840.1.113883.1.11.19579.jsonFamily Member Valueactive2024-06hl7tho3
us.nlm.vsacR4ValueSet-2.16.840.1.113883.11.20.9.38.jsonSmoking Statusactive2024-06hl7sct2
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3162.jsonRisk Factors (TB)active2008-01sct tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.801.jsonAddress Type (HL7)active2018-01tho
hl7.fhir.us.davinci-crdR4ValueSet-locationAddressType.jsonCRD Location Address Types Value Settrial-use4fm2026-03hl7fhir1
hl7.fhir.us.davinci-crd.stu3R3ValueSet-locationAddressType-stu3.jsonCRD Location Address Typesdraft2018-08hl7fhir1
hl7.fhir.us.davinci-hrexR4ValueSet-hrex-coverage-relationship.jsonHRex Coverage Relationship ValueSetdraft0cic2026-03hl7fhir tho1
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1032.313.jsonStatin Allergen Groupingactive2024-03hl7vsac
fhir.kenyaCoreIGR4ValueSet-administrative-gender-vs.jsonAdministrative Gender Value Setactive2026-01hl7fhir2
us.cdc.phinvadsR4ValueSet-2.16.840.1.113883.1.11.1.jsonAdministrative Gender (HL7 V3)active2019-01tho
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1235.645.jsonPneumococcal Vaccine HD_CN_ Allergyactive2025-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1235.638.jsonb.well Adult Tetanus Vaccine CNactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1235.648.jsonbwell COVID Vaccine CN_Metactive2025-04hl7vsac
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7758.jsonAdverse Event Severity (TB)active2017-12sct
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.963.jsonConsequence of Adverse Eventactive2008-01tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7596.jsonAdverse Event Severity (Malaria)active2019-01sct tho oid
hl7.fhir.us.registry-protocolsR4ValueSet-YesNo.jsonYes or Noactivecic2023-11hl7sct tho
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3065.jsonAge Category (Animal)active2008-01tho
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.3259.jsonAge Group (Flu)active2009-01sct tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7905.jsonAge units (ARLN)active2019-01ucum
hl7.fhir.us.davinci-pdexR4ValueSet-ProvenanceAgentType.jsonProvenance Agent Typeinformativefm2026-03hl7fhir tho1
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8054.jsonAlanine aminotransferase (ALT) Result (Hepatitis)active2021-01tho oid
hl7.fhir.us.ohsuhypertensionigR4ValueSet-2.16.840.1.113762.1.4.1032.124.jsonAlcohol Brief Intervention and Counselingactive2026-02hl7
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8019.jsonAlcohol Use Frequency (Anthrax)active2020-01sct tho oid
hl7.fhir.us.registry-protocolsR4ValueSet-StressTest.jsonCath PCI Selected Stress Testactivecic2023-11hl7loinc
fhir.cdc.opioid-cds-r4R4ValueSet-barbiturate-medications.jsonBarbiturate Medicationsactive2025-02hl72
fhir.cdc.opioid-cds-r4R4ValueSet-buprenorphine-and-methadone-medications.jsonBuprenorphine and Methadone medicationsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet-buprenorphine-medications.jsonBuprenorphine Medicationsactive2025-02hl72
fhir.dicomR4ValueSet-all.jsonAll DICOM Controlled Terminology Definitionsactive2025-07hl7dcm
hl7.fhir.us.davinci-crdR4ValueSet-ICD10CM.jsonICD10CM Disease codestrial-use4fm2026-03hl7icd1
hl7.fhir.us.icsr-ae-reportingR4ValueSet-ISBTConvalescentPlasmaCodeVS.jsonISBT Convalescent Plasma Codesdraft2023-08hl71
hl7.fhir.us.icsr-ae-reportingR4ValueSet-ISBTBloodProductCodeVS.jsonISBT Blood Product Codesdraft2023-08hl71
hl7.fhir.us.registry-protocolsR4ValueSet-SEattleAnginaQs.jsonSeattle Angina Questionsactivecic2023-11hl7loinc
fhir.tx.support.r4R4ValueSet-covid-19-obs.jsonCOVID-19 related Observation codesdraft2020-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1267.13.jsonScreening and Assessment Survey Codesactive2024-10hl7loinc3
hl7.fhir.us.davinci-crdR4ValueSet-NUBCTypeOfBill.jsonNUBC Type of Billtrial-use4fm2026-03hl71
hl7.fhir.us.davinci-crdR4ValueSet-NUCCCareProviderTaxonomyIndividualOrGroups.jsonNUCC Healthcare Provider Taxonomy Individual or Groupstrial-use4fm2026-03hl7nucc1
hl7.fhir.us.davinci-crdR4ValueSet-NUCCCareProviderTaxonomyNonIndividual.jsonNUCC Healthcare Provider Taxonomy Non-Individualtrial-use4fm2026-03hl7nucc1
fhir.cdc.opioid-cds-r4R4ValueSet-oxycodone-medications.jsonOxycodone Medicationsactive2025-02hl72
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.6053.jsonLab Test Name (Reportable Conditions)active2017-01loinc
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.6054.jsonLab Test Result (Reportable Conditions)active2016-01sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.58.jsonDiabetes Medicationsactive2022-03hl7rx
fhir.tx.support.r4R4ValueSet-covid-19-cond.jsonCOVID-19 related Condition codesdraft2020-03hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-HemodialysisOrPeritonealDialysis.jsonhemodialysis or peritoneal dialysisactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-CardiacArrest.jsonCardiac Arrestactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-CABG.jsonCoronary artery bypass graftingactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-CerebrovascularDisease.jsonCerebrovascular Diseaseactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-PeripheralArterialOcclusiveDisease.jsonPeripheral Arterial Occlusive Diseaseactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-DiabetesMellitus.jsonDiabetes Mellitusactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-Dyslipidemia.jsonDyslipidemiaactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-HeartFailure.jsonHeart Failure codes from SNOMEDactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-Hypertension.jsonHypertensionactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-PercutaneousCoronaryIntervention.jsonPCIactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-PriorCABG.jsonPrior History of Coronary Artery Bypass Graftactivecic2023-11hl7sct loinc
hl7.fhir.us.registry-protocolsR4ValueSet-HypothermiaInduced.jsonInduced Hypothermia Codesactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-OrganDonor.jsonSNOMED Valueset of Organ Donor codesactivecic2023-11hl7sct
hl7.fhir.us.registry-protocolsR4ValueSet-AbnormalElectrocardiacAssessment.jsonAbnormal Electrocardiac Assessmentactivecic2023-11hl7sct
fhir.cdc.opioid-cds-r4R4ValueSet-benzodiazepine-medications.jsonBenzodiazepine medicationsactive2025-02hl72
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.230.jsonAll Cancer Directed therapiesactive2024-05hl7rx
fhir.ph.coreR4ValueSet-educational-attainments.jsonEducational Attainmentsdraft2026-03hl71
fhir.ph.coreR4ValueSet-cities.jsonCitiesdraft2026-03hl7internal1
hl7.fhir.us.registry-protocolsR4ValueSet-FamilyPrematureCAD.jsonFamily History of Premature CADactivecic2023-11hl7sct loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.158.jsonMultiple Myeloma Regimen Drugsactive2019-08hl7rx
fhir.cdc.opioid-cds-r4R4ValueSet-naloxone-medications.jsonNaloxone medicationsactive2025-02hl72
fhir.cdc.opioid-cds-r4R4ValueSet-cdc-malignant-cancer-conditions.jsonCDC malignant cancer conditionsactive2023-05hl7icd2
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.226.jsonOpioids, Allactive2024-01hl7rx
fhir.cdc.opioid-cds-r4R4ValueSet-opioid-analgesics-with-ambulatory-misuse-potential.jsonOpioid analgesics with ambulatory misuse potentialactive2025-02hl72
fhir.cdc.opioid-cds-r4R4ValueSet-extended-release-opioid-with-ambulatory-misuse-potential.jsonExtended release opioid with ambulatory misuse potentialactive2025-02hl72
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1053.jsonCarbidopa Levodopa Combination (RXNORM)active2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2362.jsonTuberculosis (Ethambutol) (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2363.jsonTuberculosis (Isoniazid [INH]) (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2364.jsonTuberculosis (Pyrazinamide [PZA]) (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2365.jsonTuberculosis (Rifabutin) (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2366.jsonTuberculosis (Rifampin) (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2367.jsonTuberculosis (Rifapentine) (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.741.jsonHepatitis B Immune Globulin (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.747.jsonPenicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)active2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.844.jsonTuberculosis (Second Line Drugs for Treatment) (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.991.jsonRifampin (RXNORM)active2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2661.jsonEthionamide (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2662.jsonMoxifloxacin (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2663.jsonAmikacin (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2664.jsonCycloserine (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2665.jsonKanamycin (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2666.jsonPara_Amino Salicylic Acid [PAS] (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2667.jsonCapreomycin (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2668.jsonStreptomycin (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2669.jsonLevofloxacin (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.732.jsonAzidothymidine (AZT) (RXNORM)active2025-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1594.jsonHIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1595.jsonHIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1597.jsonHIV Infection (ARV Combination Treatment for HIV) (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1598.jsonHIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1600.jsonHIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1634.jsonSofosbuvir Velpatasvir Combination (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1912.jsonPenicillin G [Aqueous Crystalline] [Injectable] (RXNORM)active2023-01hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1913.jsonPenicillin G [Procaine] [Injectable] (RXNORM)active2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1078.jsonOpioid Overdose and Poisoning (Naloxone) (RxNorm)active2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1618.jsonSmallpox Vaccine (RXNORM)active2023-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2142.jsonLinezolid (RXNORM)active2023-01hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2143.jsonTuberculosis (Pretomanid) (RXNORM)active2023-01hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2144.jsonTuberculosis (Bedaquiline) (RXNORM)active2023-01hl7rx
fhir.ph.coreR4ValueSet-provinces.jsonProvincesdraft2026-03hl7internal1